Every few years, a singular health event — a pandemic, an outbreak, a natural disaster — briefly forces the world to confront the fragility of global health systems. Then the news cycle moves on. Funding commitments are quietly reduced. Political will dissipates. And the slow-moving, unglamorous crises that were already grinding away before the emergency announced itself continue to do exactly that — grind.
The year 2025 brought a striking new WHO document: the World Health Statistics Report 2025, which warned that global progress is "under threat" and that "urgent global action is needed to get back on track." Between 2019 and 2021 alone, global life expectancy fell by 1.8 years — the largest drop in recent history. The COVID-19 pandemic absorbed enormous attention and resources. But behind it, five systemic health crises were worsening, underfunded, and largely invisible to the public discourse that shapes policy and funding.
This article examines all five in depth — not as disconnected emergencies but as an interconnected system of failures, each one feeding the others. Understanding how they compound is essential to understanding why integrated action is the only path that actually works.
1.5 Billion People Trapped in a Cycle of Disease and Poverty the World Has Almost Forgotten
The name is the problem. "Neglected Tropical Diseases" — or NTDs — is a category name that functions, inadvertently, as a self-fulfilling prophecy. These are conditions whose very designation signals that they do not belong to the priority tier of global health attention. Yet in 2023, an estimated 1.495 billion people required interventions against NTDs — a figure that, even after a 32% reduction from the 2010 baseline achieved through sustained global effort, remains staggering in its human scale. And critically, the funding environment that enabled that progress is now deteriorating sharply.
The WHO's Global Report on Neglected Tropical Diseases 2025 — marking 20 years of the WHO's NTD programme — documented that global official development assistance (ODA) for NTDs fell by 41% between 2018 and 2023. That collapse in funding threatens to reverse hard-won gains that took decades to accumulate. The economic case for continued investment is overwhelming: every USD 1 invested in NTD preventive chemotherapy yields an estimated return of around USD 25. NTDs cost affected families and communities approximately USD 33 billion annually in lost wages and out-of-pocket expenses. And yet the political priority assigned to these conditions remains, true to their name, negligible.
The twenty NTDs recognised by the WHO include diseases that most people in wealthy nations have never encountered: lymphatic filariasis, trachoma, schistosomiasis, visceral leishmaniasis, leprosy, dengue fever, rabies, soil-transmitted helminthiases, and more. They thrive in environments of poverty, inadequate sanitation, contaminated water, and limited healthcare access. They are, in a precise biological sense, diseases of inequality — diseases that occur where vulnerability intersects with neglect.
The mental health dimension of NTDs is one of the most severely under-resourced gaps in global health. Skin-related NTDs, including leprosy and cutaneous leishmaniasis, carry enormous psychosocial burdens: severe stigma, social exclusion, family abandonment, and deep clinical depression are consistent features of these conditions across multiple continents. A person whose face has been disfigured by leishmaniasis, or whose limbs have been grotesquely swollen by lymphatic filariasis, faces not only physical suffering but a profound disruption of identity, social belonging, and economic participation. The WHO's 2026 World NTD Day campaign specifically called for integrating mental health into NTD responses — a recognition that treating the disease without treating the person leaves the majority of the burden unaddressed.
- 1.495 billion people required NTD interventions in 2023 — WHO Global NTD Report 2025
- 41% decline in official development assistance for NTDs between 2018 and 2023
- USD 33 billion in annual losses to affected families from NTDs
- $1 invested = $25 returned — the return on NTD preventive chemotherapy
- 58 countries have eliminated at least one NTD as of 2025, against a target of 100 by 2030
- 867.1 million people treated for NTDs in 2023 — a record
Progress is real and should be acknowledged: 58 countries had eliminated at least one NTD by 2025, and 867.1 million people were treated in 2023. These achievements demonstrate that when funding, coordination, and political will align, these diseases can be controlled and eliminated. But the 41% funding drop arrives precisely when the final mile — reaching the most geographically and socially remote communities — is the hardest and most expensive stretch. Without renewed commitment, the most vulnerable people on Earth will pay the price for donor fatigue.
The System That Keeps Everyone Alive Is Running Out of the People Who Run It
A healthcare system without healthcare workers is not a healthcare system — it is an aspiration. And yet the world is approaching a scenario where the gap between the number of health workers needed and the number available is measured in the tens of millions. The WHO's latest projections, updated in 2025, put the global healthcare workforce shortage at 11.1 million by 2030 — an upward revision from earlier estimates, reflecting a slowing pace of progress and an accelerating pace of demand. McKinsey's analysis of the same data found that closing this gap could avert 189 million years of life lost and generate USD 1.1 trillion in economic returns. The world is leaving both the health outcomes and the economic gains on the table.
The geography of the crisis is not uniform. Over half the global shortfall will be concentrated in Northern and sub-Saharan Africa. Budget cuts identified in a March 2025 WHO rapid assessment — in which 63% of country offices reported job-related effects on health workers — are projected to increase the workforce shortage in Africa by an additional 600,000 workers compared to earlier estimates. The International Council of Nurses forecasts a specific deficit of 13 million nurses by 2030 — equivalent to the entire nursing workforce of Europe. These are not figures that can be solved by minor adjustments to training pipelines. They require structural transformation.
Burnout sits at the intersection of every dimension of this crisis. Project HOPE's analysis found that the global shortfall is being driven substantially by burnout and mental health challenges as major factors in workforce attrition. Around one-third of health workers globally continue to experience burnout — a rate that, while improved from pandemic peaks, remains persistently elevated due to staffing shortages, unsustainable workloads, and systemic under-investment in worker wellbeing. Over 60% of health workers face workplace violence. Women, who comprise 67% of the global health workforce but 75% of unpaid healthcare labour globally, bear the greatest burden of these systemic failures.
The crisis operates in a vicious cycle. Understaffing causes burnout, which causes attrition, which causes worse understaffing. In underserved and rural regions, where a single doctor may serve tens of thousands of people, the loss of even one healthcare worker to burnout, migration, or career exit can dismantle access to essential care for an entire community. The quality of care in these settings suffers not because of a lack of medical knowledge but because the humans who carry and deliver that knowledge are being systematically overworked and under-supported.
- 11.1 million health worker shortfall projected by 2030 — WHO 2025 updated forecast
- 13 million nurse deficit projected globally by 2030 — International Council of Nurses
- Over 1/3 of health workers experiencing burnout globally — Project HOPE
- 60%+ face workplace violence, driving turnover — OUCRU analysis 2025
- 63% of WHO country offices reported job-related effects on workers — March 2025 rapid assessment
- 66% of critical care nurses considered leaving the profession during the pandemic
Innovation is part of the answer. McKinsey's report identified that virtual reality training programmes have increased licensure examination pass rates by 10% in nursing curricula, and that scalable digital education pathways offer routes to expand healthcare capacity in areas with limited traditional educational infrastructure. But technology cannot substitute for the structural changes — fair pay, safe working conditions, genuine mental health support, and adequate staffing ratios — that determine whether trained health workers actually stay in the profession. In 2024 alone, Project HOPE trained more than 33,000 health workers worldwide — a meaningful contribution, but orders of magnitude below what the scale of the crisis demands.
43 Million Deaths a Year, a Billion People Living With Obesity, and Progress Is Going Backwards
Noncommunicable diseases — the chronic, non-transmissible conditions including cardiovascular disease, cancer, chronic respiratory disease, and diabetes — killed at least 43 million people in 2021, according to WHO's UHC dashboard. That figure represents approximately 75% of all non-pandemic-related deaths globally. Of those 43 million, 18 million were people who died before reaching the age of 70 — deaths that by virtually any clinical definition were premature and largely preventable. Cardiovascular diseases remain the single largest category, claiming at least 19 million lives, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million, including diabetes-driven kidney disease).
Obesity is the engine driving much of this. In 2025, the WHO confirmed that more than one billion people worldwide are now living with obesity — a figure that would have seemed grotesquely implausible two generations ago. Obesity is no longer a condition of affluence; it is a global epidemic that is growing fastest in low- and middle-income countries, driven by the industrialisation of food systems, urban environments designed for motorised transport, and the structural economic conditions that make processed, calorie-dense food the cheapest option for billions of people. The global economic impact of obesity was nearly USD 2 trillion in 2020 and is projected to exceed USD 3 trillion by 2030 and USD 18 trillion by 2060.
The WHO's World Health Statistics Report 2025 delivered a sobering warning: the world is currently off track to reduce NCD premature mortality by one-third by 2030 — a target set years ago that the global community is now demonstrably failing to meet. Premature deaths from NCDs are rising, driven by population growth, ageing, and the compounding effects of obesity-related metabolic conditions. The report noted that while tobacco use has declined and alcohol consumption dropped modestly, these gains are being overwhelmed by the trajectory of obesity, physical inactivity, and unhealthy diets.
In response to the scale of the obesity crisis, WHO released its first-ever recommendations in 2025 on the use of GLP-1 therapies — the class of weight-loss drugs that includes semaglutide — for treating obesity. This marks a significant shift in official guidance, signalling that the medical establishment has moved beyond purely behavioural approaches. But GLP-1 therapies at their current cost remain inaccessible to the vast majority of people with obesity globally — precisely those in low- and middle-income countries where the epidemic is accelerating. A treatment that works only for those who can afford it does not solve a structural public health crisis; it deepens the inequality that defines it.
- 43 million deaths per year from NCDs — 75% of all non-pandemic global deaths
- 1 billion+ people currently living with obesity — WHO 2025
- 18 million premature NCD deaths before age 70, annually; 82% in LMICs
- USD 18 trillion — projected global economic cost of obesity by 2060
- World off-track to meet 2030 NCD mortality reduction targets — WHO World Health Statistics 2025
- Air pollution alone causes 6.7 million NCD deaths annually — WHO fact sheet
The prevention and care disparities between wealthy nations and the rest of the world are a defining ethical failure of contemporary global health. In high-income countries, people with heart disease, diabetes, or cancer can access screening, early intervention, lifestyle modification programmes, and medications that substantially reduce their mortality risk. In low- and middle-income countries — where 73% of NCD deaths occur — many of these tools simply do not exist, are unaffordable, or are inaccessible due to geographical or infrastructural barriers. The tragedy, as one clinical review summarises it plainly, is that most NCD morbidity and mortality could be prevented or delayed — and millions could live longer, healthier lives — if the political and financial will to prioritise prevention in the communities most affected were mobilised.
The Invisible Killer: 7.9 Million Deaths a Year That Nobody Treats as a Crisis
Imagine a disease that kills 7.9 million people every year — more than AIDS, malaria, and tuberculosis combined. A disease that affects virtually every person on Earth. A disease whose deadliest agent penetrates the lungs, enters the bloodstream, and damages the heart, the brain, the kidneys, and the developing foetuses of pregnant women. Now imagine that this disease was caused largely by human activity and was, in principle, substantially controllable. You have described air pollution — and the global response to it remains scandalously inadequate relative to its toll.
The State of Global Air 2025 Report, released by the Health Effects Institute in October 2025, confirmed that air pollution contributed to 7.9 million deaths in 2023, remaining the leading environmental risk factor for death worldwide. Of those deaths, 86% — approximately 6.8 million — were from noncommunicable diseases. Between 2000 and 2023, NCD deaths from air pollution increased from 5.99 million to 6.8 million: nearly a million additional deaths, or 110 additional deaths every single day. Half of all chronic respiratory disease deaths are directly attributable to air pollution. One in four deaths from heart disease carries an air pollution contribution.
The 2025 report also introduced dementia data for the first time, finding that air pollution-attributable dementia resulted in over 600,000 deaths and nearly 12 million healthy years of life lost in 2023 alone. A WHO commentary published in July 2025 noted that emerging evidence now links air pollution to asthma, impaired kidney function, cognitive decline, and mental health disorders including depression and anxiety — extending the health burden far beyond the respiratory and cardiovascular systems that have historically dominated the research literature.
Children and older adults face disproportionate risk. In 2021, air pollution was linked to more than 700,000 deaths in children under five — making it the second-leading risk factor for death in that age group after malnutrition. Particulate matter smaller than 2.5 micrometres (PM2.5), produced by vehicle exhaust, industrial emissions, agricultural burning, and household cooking fires, is the most pervasive and lethal component of air pollution, accounting for more than 90% of air pollution-related deaths. PM2.5 is so small it remains in the lungs and enters the bloodstream, causing systemic inflammation that over years and decades translates into cardiovascular disease, metabolic disorders, and neurological damage.
The distribution of this burden is profoundly unequal. The largest health impacts from air pollution are concentrated in low- and middle-income countries — particularly sub-Saharan Africa and South and Southeast Asia — where people have both the highest exposures and the most limited access to healthcare. Household air pollution, driven by the use of solid fuels for cooking and heating in poorly ventilated spaces, kills roughly 3.2 million people annually and is a primary driver of poverty-related premature death. This is a technological and economic problem with known, affordable solutions — clean cooking stoves, cleaner fuels, improved ventilation — that remain out of reach for hundreds of millions of families because development funding and governmental priority have not been directed there at the necessary scale.
- 7.9 million deaths attributed to air pollution in 2023 — State of Global Air 2025 (HEI)
- 6.8 million NCD deaths linked to air pollution (86% of total)
- 110 additional NCD deaths every day since 2000 due to air pollution — 13% increase
- 700,000+ children under-5 deaths linked to air pollution in 2021
- 600,000 dementia deaths attributed to air pollution — first documented in 2025 report
- Half of all COPD deaths worldwide are attributable to air pollution
The political economy of air pollution is one of the key reasons it remains so inadequately addressed. Its causes are deeply embedded in economic activity — fossil fuel combustion, industrial production, transportation, agriculture — and therefore confront entrenched financial interests resistant to regulation and transition costs. In rapidly industrialising nations, governments face the genuine dilemma of balancing economic development against environmental health, often in contexts where regulatory institutions are underdeveloped. Meanwhile, development funders and multilateral institutions have historically under-prioritised environmental health relative to other global health priorities, creating a chronic gap between the scale of the problem and the resources directed at it.
War, Famine, and Climate Collapse Are Bringing Back Diseases We Almost Defeated
In the annals of modern public health, few achievements have been as collectively hard-won as the near-eradication of diseases like polio, and the sustained reductions in malaria mortality that saved millions of children's lives over two decades. In 2025, both of those achievements are under genuine threat — not from scientific failure, but from the collapse of the political and logistical conditions necessary for health systems to function in the world's most conflict-affected regions.
Armed conflicts, extreme food insecurity, mass displacement, and climate shocks have devastated healthcare infrastructure across dozens of countries. When hospitals are bombed, supply chains collapse, healthcare workers flee, vaccination campaigns cannot reach populations, and disease surveillance systems go dark — diseases that were controlled begin to resurge. Malaria, cholera, measles, and polio have all experienced localised resurgences in conflict-affected regions where the infrastructure of elimination has been destroyed faster than it can be rebuilt.
On the malaria front, the overall global picture contains real progress: in 2025, Georgia, Suriname, and Timor-Leste were certified malaria-free, and 24 countries have now introduced malaria vaccines, reaching over 10 million children annually. Wider use of dual-ingredient mosquito nets and WHO-recommended vaccines helped prevent an estimated 170 million cases and 1 million deaths in 2024. But these headline figures mask a deeply concerning pattern in conflict-affected sub-Saharan African nations where malaria programmes have been disrupted by violence, funding cuts, and the breakdown of community health infrastructure. Drug-resistant malaria strains are spreading in Southeast Asia. And in several previously low-burden countries, resurgent transmission is occurring precisely where health systems have been weakened by humanitarian emergencies.
Polio presents a parallel situation. The Global Polio Eradication Initiative has brought the world closer to eliminating wild poliovirus than at any previous point in history, with wild poliovirus type 1 now endemic only in Pakistan and Afghanistan. But circulating vaccine-derived poliovirus (cVDPV) — a form of the virus that emerges when oral polio vaccines circulate in under-immunised populations — has been detected in an expanding number of countries. The conditions that create cVDPV outbreaks are precisely the conditions generated by conflict and displacement: interrupted vaccination campaigns, populations moving across borders, overwhelmed health systems, and surveillance gaps in contested territory.
- 170 million malaria cases and 1 million deaths prevented in 2024 by scale-up of interventions
- 700,000+ additional maternal deaths at risk if 2030 UHC targets are missed — WHO 2025
- 8 million under-5 deaths at risk without urgent course correction to 2030 targets
- cVDPV (circulating vaccine-derived poliovirus) detected in conflict-affected nations despite near-eradication of wild poliovirus
- Global life expectancy fell 1.8 years between 2019 and 2021 — largest drop in modern history
- Essential health service coverage still below 2019 levels in most conflict-affected regions
The interconnection between climate change and disease resurgence is one of the most alarming emerging dimensions of this crisis. Rising temperatures are expanding the geographic range of malaria, dengue, and other vector-borne diseases into previously unaffected regions. Extreme weather events destroy health infrastructure and trigger population displacement that overwhelms receiving communities. The Lancet Countdown 2025 warned explicitly that climate inaction is killing millions and called for health-centred climate policies — a call that the international climate negotiation process has yet to internalise with adequate urgency.
The coordinated cross-border disease surveillance systems that contain outbreaks before they become epidemics are precisely the systems that break down in humanitarian emergencies. When health information systems go dark, when laboratory capacity is destroyed, when the epidemiologists and community health workers who form the early-warning network are displaced or killed, diseases spread undetected until they are already beyond easy containment. Rebuilding that capacity in active conflict zones requires financing, political access, and logistical creativity that the current architecture of international humanitarian health response often fails to provide.
Why These Five Crises Must Be Addressed Together
These five crises are not parallel — they are interlocked. NTDs disproportionately affect people who are also most exposed to indoor air pollution, most likely to develop NCDs in the absence of adequate nutrition and healthcare, and most likely to live in regions destabilised by conflict. A healthcare workforce that is burning out and shrinking cannot address any of these five challenges at the necessary scale. Humanitarian emergencies that destroy health infrastructure set back NTD elimination programmes, reduce vaccination coverage that prevents childhood deaths, and create conditions for disease resurgence that reverse decades of painstaking progress.
The WHO's 2025 World Health Statistics Report identified the common thread running through all of them: a "longer trend of slowing progress" that predates the pandemic, followed by a recovery that is insufficient to get back on track. The world is, by virtually every meaningful metric, under-investing in the health systems, workforce, and interventions needed to address the compounding disease burden of the 21st century.
What does "adequate response" actually look like? It looks like closing the 41% funding gap for NTD programmes before the elimination momentum built over 20 years reverses. It looks like structurally reforming health workforce conditions — pay, safety, mental health support, career pathways — so that health systems can retain the professionals they train. It looks like moving NCD prevention upstream, into food systems, urban design, and fiscal policy, rather than treating it exclusively as an individual clinical problem. It looks like mandating clean energy transitions and clean cooking solutions with the same urgency that climate negotiations have applied to carbon targets. And it looks like building humanitarian health response systems that are proactive and resilient rather than reactive and perpetually under-resourced.
None of this is technologically impossible. The science exists. The interventions are known. The economic case is unambiguous — in every single one of these five areas, prevention and early intervention deliver returns that dwarf the cost of inaction. What has been insufficient is political will, equitable financing, and the kind of sustained public and journalistic attention that holds decision-makers accountable for the gap between what is possible and what is actually being done.
The WHO's World NTD Day 2026 put it simply: the call is to "safeguard past progress, mobilise new funding and leadership, accelerate innovation, and integrate health services." That formulation could equally serve as the agenda for all five of these crises. The question is whether the world will answer the call before the window for doing so at manageable cost has closed.
0 Comments